Strategies and recommendations for driving value in today’s AI-enhanced prescribing environment.
Kamini Anbil
Advertisement
Kamini Anbil is a consultant with The ConfluenceElite Group, LLC. She can be reached at Kamini.anbil@gmail.com
Articles by Kamini Anbil
The window of opportunity for launch is short and unforgiving, and the success depends on flawless execution of launch activity across countries and functions.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Most Favored Nation Order: Legal Battles, Market Shifts, and the Future of Drug Pricing Reform
2
FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
3
Novo Nordisk Enters $4.7 Billion Definitive Agreement with Akero Therapeutics
4
Bristol Myers Squibb Enters $1.5 Billion Definitive Agreement Acquiring Orbital Therapeutics
5
